Dear Reader,
Welcome to the July edition of Master Investor Magazine. Once again we have an exciting line-up of content from our stable of high calibre contributors, all of whom are seasoned investors/traders in their own right. In this month's issue of Master Investor Magazine, we take to the skies to discover how the next phase of growth in air travel could give your portfolio wings...
 | In this month's Master Investor Magazine |
MELLON ON THE MARKETS
TIME FOR TAKE-OFF - HOW GROWTH IN GLOBAL AIR TRAVEL CAN LIFT YOUR PORTFOLIO HOW TO INVEST LIKE... JOHN TEMPLETON THE DIVIDEND HUNTER - DEBT-FREE DIVIDEND INVESTING FUNDS IN FOCUS - FUNDS TO COLLECT THE GREY POUND FROM ACORNS TO OAK TREES - SPECIAL-DIVIDEND SPECIAL THE MACRO INVESTOR - THE DEATH OF BONDS OPPORTUNITIES IN FOCUS - FORGET PHARMACEUTICALS - THINK IMMUNOLOGY AND SYNTHETIC BIOLOGY CHART NAVIGATOR - TAKE ME UP THE NORTHWEST PASSAGE ROBBIE BURNS' TRADING DIARY FORENSIC FOREX- WHERE NEXT FOR STERLING WHAT WENT WRONG AT STANLEY GIBBONS? ALL ABOARD THE BREXIT BIG DIPPER! MILLENNIALS & MONEY - CROWDFUNDING: IS IT WORTH THE EFFORT? BEST OF THE BLOG READ TO SUCCEED - THE RULES OF WEALTH THE FINAL WORD - SOLDIERS OF FORTUNE MARKETS IN FOCUS
Companies and funds covered in this month's issue include: Lloyds Banking Group, Barclays, RBS, EasyJet, All Leisure Group, Boeing, Rolls-Royce, B/E Aerospace, Airbus, Toray Industries, Hexcel Corporation, Victrex, General Electric, Air Lease Corp., Inmarsat, AAR Corp., WH Smiths, Ryanair, The Restaurant Group, XP Power, PayPoint, UK Mail, CPR Silver Age, Woodford Equity Income, Artemis Global Select, Polar Capital Healthcare Opportunities, AXA Framlington Health, Pictet Health, Worldwide Healthcare Trust, Polar Capital Global Healthcare and Income Trust, Target Healthcare Real Estate Investment Trust, MedicX Fund Limited, James Halstead, Secure Trust Bank, Gem Diamonds, Avesco, Stock Spirits, Castings, Sportech, Pfizer, Sanofi SA, Novartis, GlaxoSmithKline, Merck AG, Bristol Myers Squibb Corp., Ono Pharmaceutical Co Ltd., Roche, Teva Pharmaceuticals, AstraZeneca, Eli Lilly & Co., Biondvax Pharmaceuticals, Johnson & Johnson, Bavarian Nordic A/S, Inovio Pharmaceutical Inc., Aduro Biotech Inc., Vertex Pharmaceuticals, Fidelity Select Biotechnology Portfolio, Loncar Cancer Immunotherapy ETF, Juno Therapeutics, Kite Pharma, iShares MSCI Denmark Capped Investable Market Index Fund, Lyxor UCITS ETF DJ Global Titans 50 D-£, Flying Brands, Stanley Gibbons, Tesco, Monsanto. With all this and more besides in this month's issue of Master Investor Magazine, what are you waiting for? 
Swen Lorenz
Editor, Master Investor Magazine
P.S. Are you following our Facebook channel? That's where we are publishing travel notes from our contributors, summaries of our latest articles, and bite-sized background information about topics we are covering in the magazine. If you haven't already friended us, visit us on www.facebook.com/masterinvestor.
Please visit us at www.masterinvestor.co.uk. |
